Shuttle Pharmaceuticals Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($2.35M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($3.71M) | Aug 13, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($3.71M) | Nov 13, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($3.05M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($3.05M) | May 8, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($3.05M) | Nov 13, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($3.78M) | Nov 13, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($2.03M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.03M) | Aug 13, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($1.73M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.73M) | May 8, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($1.73M) | Nov 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.79M) | Nov 13, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($2.18M) | Nov 13, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.18M) | Sep 4, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($975.1K) | Sep 4, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($975.1K) | Nov 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($975.1K) | Sep 4, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($998.4K) | Nov 13, 2023 |
| Q3 | 2023 | Jun 30, 2022 | ($597.3K) | Nov 13, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($2.27M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($3.91M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($2.95M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($3.05M) | Nov 13, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($1.48M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.38M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.60M) | Nov 13, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.47M) | Sep 4, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.54M) | Sep 4, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($821.5K) | Nov 13, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($353.6K) | Aug 14, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($638.4K) | May 25, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($242.1K) | Nov 14, 2022 |